Aberdeen Group Portfolio holdings
AUM
$58.8B
1-Year Return
21.66%
This Quarter Return
+12.43%
1 Year Return
+21.66%
3 Year Return
+94.43%
5 Year Return
+162.75%
10 Year Return
–
AUM
$46.1B
AUM Growth
+$6.94B
(+18%)
Cap. Flow
+$2.42B
Cap. Flow
% of AUM
5.24%
Top 10 Holdings %
Top 10 Hldgs %
24.2%
Holding
995
New
107
Increased
596
Reduced
238
Closed
35
Top Buys
| 1 |
NVIDIA
NVDA
|
$247M |
| 2 |
Amgen
AMGN
|
$181M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$164M |
| 4 |
Johnson & Johnson
JNJ
|
$161M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$157M |
Top Sells
| 1 |
Broadcom
AVGO
|
$244M |
| 2 |
Microsoft
MSFT
|
$221M |
| 3 |
Emerson Electric
EMR
|
$205M |
| 4 |
TJX Companies
TJX
|
$204M |
| 5 |
Fiserv
FI
|
$185M |
Sector Composition
| 1 | Technology | 27.07% |
| 2 | Healthcare | 17.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Williams Companies
WMB
$69.9B
| $51.1M | 0.11% |
1,466,438
+223,139
| +18% | +$7.77M |
|
202
Graphic Packaging
GPK
$6.38B
| $51M | 0.11% |
2,067,312
-210,981
| -9% | -$5.2M |
|
203
Crown Holdings
CCK
$11B
| $50.6M | 0.11% |
549,676
-49,027
| -8% | -$4.51M |
|
204
Boston Properties
BXP
$12.2B
| $50.1M | 0.11% |
713,840
+28,870
| +4% | +$2.03M |
|
205
Genuine Parts
GPC
$19.4B
| $49.7M | 0.11% |
358,593
+85,279
| +31% | +$11.8M |
|
206
RTX Corp
RTX
$211B
| $49.5M | 0.11% |
588,321
+244,319
| +71% | +$20.6M |
|
207
Fabrinet
FN
$13.2B
| $49.4M | 0.11% |
259,712
-69,691
| -21% | -$13.3M |
|
208
Starbucks
SBUX
$97.1B
| $49.3M | 0.11% |
513,384
+189,330
| +58% | +$18.2M |
|
209
Baxter International
BAX
$12.5B
| $49M | 0.11% |
1,267,898
+425,951
| +51% | +$16.5M |
|
210
LKQ Corp
LKQ
$8.33B
| $48.5M | 0.11% |
1,015,499
+113,145
| +13% | +$5.41M |
|
211
FedEx
FDX
$53.7B
| $48.4M | 0.1% |
191,132
+43,053
| +29% | +$10.9M |
|
212
Moderna
MRNA
$9.78B
| $48.1M | 0.1% |
483,574
+399,843
| +478% | +$39.8M |
|
213
PayPal
PYPL
$65.2B
| $47.9M | 0.1% |
779,260
+128,746
| +20% | +$7.91M |
|
214
Nice
NICE
$8.67B
| $47.7M | 0.1% |
239,194
-452,409
| -65% | -$90.3M |
|
215
DexCom
DXCM
$31.6B
| $47.2M | 0.1% |
380,535
+66,348
| +21% | +$8.23M |
|
216
Illumina
ILMN
$15.7B
| $47.2M | 0.1% |
348,516
+308,223
| +765% | +$41.7M |
|
217
Pentair
PNR
$18.1B
| $46.7M | 0.1% |
642,390
+79,809
| +14% | +$5.8M |
|
218
CyberArk
CYBR
$23.3B
| $46.1M | 0.1% |
210,342
-99,457
| -32% | -$21.8M |
|
219
First Solar
FSLR
$22B
| $45.9M | 0.1% |
266,648
+35,445
| +15% | +$6.11M |
|
220
Regions Financial
RF
$24.1B
| $45.5M | 0.1% |
2,350,151
+341,878
| +17% | +$6.63M |
|
|
CNH
221
CNH Industrial
CNH
$14.3B
| $45.2M | 0.1% |
+3,713,663
| New | +$45.2M |
|
222
Owens Corning
OC
$13B
| $45.2M | 0.1% |
304,867
+22,609
| +8% | +$3.35M |
|
223
Molson Coors Class B
TAP
$9.96B
| $45M | 0.1% |
735,184
+84,856
| +13% | +$5.19M |
|
224
Estee Lauder
EL
$32.1B
| $44.6M | 0.1% |
304,823
+39,738
| +15% | +$5.81M |
|
225
Alnylam Pharmaceuticals
ALNY
$59.2B
| $44.5M | 0.1% |
232,716
+209,691
| +911% | +$40.1M |
|